ZA200200390B - Use of interleukin-18 inhibitors to inhibit tumor metastasis. - Google Patents

Use of interleukin-18 inhibitors to inhibit tumor metastasis.

Info

Publication number
ZA200200390B
ZA200200390B ZA200200390A ZA200200390A ZA200200390B ZA 200200390 B ZA200200390 B ZA 200200390B ZA 200200390 A ZA200200390 A ZA 200200390A ZA 200200390 A ZA200200390 A ZA 200200390A ZA 200200390 B ZA200200390 B ZA 200200390B
Authority
ZA
South Africa
Prior art keywords
interleukin
inhibitors
tumor metastasis
inhibit tumor
inhibit
Prior art date
Application number
ZA200200390A
Other languages
English (en)
Inventor
Charles Dinarello
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of ZA200200390B publication Critical patent/ZA200200390B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200200390A 1999-07-22 2002-01-16 Use of interleukin-18 inhibitors to inhibit tumor metastasis. ZA200200390B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors

Publications (1)

Publication Number Publication Date
ZA200200390B true ZA200200390B (en) 2003-04-30

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200390A ZA200200390B (en) 1999-07-22 2002-01-16 Use of interleukin-18 inhibitors to inhibit tumor metastasis.

Country Status (31)

Country Link
US (1) US7741276B2 (enExample)
EP (1) EP1206274B1 (enExample)
JP (1) JP4827352B2 (enExample)
KR (1) KR100682219B1 (enExample)
CN (1) CN1173736C (enExample)
AR (1) AR024907A1 (enExample)
AT (1) ATE363288T1 (enExample)
AU (1) AU782478B2 (enExample)
BG (1) BG65800B1 (enExample)
BR (1) BR0012675A (enExample)
CA (1) CA2380216C (enExample)
CY (1) CY1107932T1 (enExample)
CZ (1) CZ302114B6 (enExample)
DE (2) DE60035049T2 (enExample)
DK (1) DK1206274T3 (enExample)
EA (1) EA005419B1 (enExample)
EE (1) EE04838B1 (enExample)
ES (1) ES2186596T3 (enExample)
HK (1) HK1048248B (enExample)
HU (1) HU228780B1 (enExample)
IL (2) IL131047A0 (enExample)
MX (1) MXPA02000838A (enExample)
NO (1) NO329827B1 (enExample)
NZ (1) NZ516535A (enExample)
PL (1) PL202477B1 (enExample)
PT (1) PT1206274E (enExample)
SK (1) SK287522B6 (enExample)
TR (1) TR200200169T2 (enExample)
UA (1) UA73745C2 (enExample)
WO (1) WO2001007480A2 (enExample)
ZA (1) ZA200200390B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI373343B (en) * 2000-02-10 2012-10-01 Abbott Gmbh & Co Kg Antibodies that bind human interleukin-18 and methods of making and using
CA2424983A1 (en) 2000-10-11 2002-04-18 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
MXPA03010575A (es) * 2001-05-16 2005-03-07 Yeda Res & Dev Uso de inhibidores de il-08 para el tratamiento o prevencion de sepsis.
RU2225720C1 (ru) * 2002-08-12 2004-03-20 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана
WO2004032837A2 (en) * 2002-10-08 2004-04-22 Ares Trading S.A. The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
EP2267024B1 (en) 2005-06-03 2012-05-09 Ares Trading S.A. Production of recombinant Il-18 binding protein
SI1891088T1 (sl) 2005-06-10 2012-02-29 Ares Trading Sa Postopek za äśiĺ äśenje il-18 vezavnega proteina
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
PE20251671A1 (es) 2022-03-15 2025-06-30 Compugen Ltd Anticuerpos antagonistas de il-18bp y su uso en monoterapia y terapia de combinacion en el tratamiento del cancer
WO2024148243A1 (en) 2023-01-06 2024-07-11 Lassen Therapeutics 1, Inc. Anti-il-18bp antibodies
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2732546B2 (ja) * 1992-09-02 1998-03-30 アイシス・ファーマシューティカルス・インコーポレーテッド 細胞接着のオリゴヌクレオチド調節
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
CN1269722A (zh) * 1997-03-18 2000-10-11 Basf公司 调节对皮质类固醇反应的方法及组合物
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
CN1173736C (zh) 2004-11-03
JP2003505472A (ja) 2003-02-12
PL202477B1 (pl) 2009-06-30
CA2380216A1 (en) 2001-02-01
NO20020153D0 (no) 2002-01-11
HUP0202107A3 (en) 2005-01-28
EP1206274B1 (en) 2007-05-30
ES2186596T3 (es) 2007-11-16
JP4827352B2 (ja) 2011-11-30
NO329827B1 (no) 2011-01-03
PL353732A1 (en) 2003-12-01
DK1206274T3 (da) 2007-08-13
KR20020027493A (ko) 2002-04-13
DE60035049D1 (de) 2007-07-12
AU5843200A (en) 2001-02-13
ES2186596T1 (es) 2003-05-16
EE200200032A (et) 2003-02-17
TR200200169T2 (tr) 2002-06-21
US20080003216A1 (en) 2008-01-03
DE60035049T2 (de) 2007-09-27
AU782478B2 (en) 2005-08-04
KR100682219B1 (ko) 2007-02-12
SK287522B6 (sk) 2011-01-04
CY1107932T1 (el) 2013-09-04
EP1206274A2 (en) 2002-05-22
HK1048248A1 (en) 2003-03-28
BG65800B1 (bg) 2009-12-31
US7741276B2 (en) 2010-06-22
NZ516535A (en) 2004-04-30
BRPI0012675B8 (enExample) 2021-05-25
HK1048248B (zh) 2005-04-22
EE04838B1 (et) 2007-06-15
EA005419B1 (ru) 2005-02-24
WO2001007480A2 (en) 2001-02-01
CA2380216C (en) 2012-01-31
ATE363288T1 (de) 2007-06-15
BG106311A (en) 2002-08-30
MXPA02000838A (es) 2002-07-30
BR0012675A (pt) 2002-04-09
DE1206274T1 (de) 2002-11-14
IL131047A0 (en) 2001-01-28
SK882002A3 (en) 2002-07-02
HU228780B1 (en) 2013-05-28
UA73745C2 (en) 2005-09-15
AR024907A1 (es) 2002-10-30
HUP0202107A2 (en) 2002-10-28
CN1364086A (zh) 2002-08-14
IL147675A (en) 2009-05-04
CZ2002195A3 (cs) 2002-06-12
CZ302114B6 (cs) 2010-10-20
WO2001007480A3 (en) 2001-05-10
BRPI0012675B1 (pt) 2001-02-01
NO20020153L (no) 2002-03-11
PT1206274E (pt) 2007-07-06
EA200200189A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
ZA200108413B (en) Use of glycosyceramide synthesis inhibitors in therapy.
AU8419201A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
IL156064A0 (en) Vla-4 inhibitors
GB0025782D0 (en) Use of inhibitors
IL146518A0 (en) Metalloprotease inhibitors
ZA200306490B (en) Inhibitors of factor Xa.
AU4107801A (en) Alpha-amylase activity inhibitors
MXPA03000694A (es) Nuevo uso de los inhibidores de lipasa.
ZA200200390B (en) Use of interleukin-18 inhibitors to inhibit tumor metastasis.
ZA200106197B (en) Use of glycogen phosphorlase inhibitors to inhibit tumor growth.
AU8323701A (en) Inhibitors of p38
PL350452A1 (en) Dihetero-substituted metalloprotease inhibitors
AU2001236052A1 (en) Urease inhibitors
AU2001285325A1 (en) Use of threo-methylphenidate compounds to enhance memory
GB0030284D0 (en) Enzyme inhibitors
GB9924522D0 (en) Enzyme inhibitors
EP1173429A4 (en) PROTEASE INHIBITORS
EP1229911A4 (en) PROTEASE INHIBITORS
SI1206274T1 (sl) Uporaba zaviralcev interlevkina-18 za zaviranje tumorske metastaze
MXPA01009617A (es) Sisntesis de propanoatos de 3-amino-3-arilo.
AU2001290241A1 (en) Tumor cell proliferation inhibitors
AU2003299137A8 (en) Inhibition of metallo-beta-lactamase
ZA200205471B (en) Use of IL-18 inhibitors.
GB0109278D0 (en) Enzyme inhibitors
AU2003228532A8 (en) Methods of use of the enzymes of mycothiol synthesis